Long-term somatic side-effects and morbidity in testicular cancer patients
1990

Long-term Side Effects in Testicular Cancer Patients

Sample size: 149 publication Evidence: moderate

Author Information

Author(s): N. Aass, S. Kaasa, E. Lund, O. Kaalhus, M. Skard Heier, S.D. Foss

Primary Institution: The Norwegian Radium Hospital

Hypothesis

What are the long-term somatic side-effects and morbidity experienced by testicular cancer patients after treatment?

Conclusion

Three to seven years after treatment for testicular cancer, 30-50% of patients reported minor somatic complaints, but serious side effects were rare.

Supporting Evidence

  • Raynaud-like phenomena were reported significantly more often in patients treated with cisplatin-based chemotherapy.
  • 18% of patients reported peripheral sensory neuropathy.
  • 40% of patients reported gastrointestinal side effects after treatment.

Takeaway

After getting treated for testicular cancer, many patients feel some minor health issues, but most are doing well and have few serious problems.

Methodology

Patients completed a questionnaire regarding their health status after treatment, and their medical records were reviewed.

Potential Biases

Self-reported data may lead to under-reporting of symptoms.

Limitations

The study relied on patient-reported outcomes without supplementary clinical examinations.

Participant Demographics

149 patients with no evidence of disease for at least 3 years, treated between 1978 and 1981.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication